Synteract Launches Rare Disease Institute


Applied Clinical Trials

Synteract has launched the Synteract Rare Disease Institute. The program incorporates lectures, webinars, interactive discussions, videos, and industry literature that cover a wide variety of topics from patient perspectives, bioethics to customer engagement and more.

For more information, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.